Your search returned 81 studies. (Get alerts for new studies):
- Efficacy and Safety of Zoledronic Acid ( Every 4 Weeks vs. Every 12 Weeks) in Patients With Documented Bone Metastases From Bone Cancer
Conditions: Breast Cancer
Location: Lafayette, Louisiana
- A Safety and Efficacy Study of the Birmingham Hip Resurfacing System
Conditions: Arthritis
Location: Lake Charles, Louisiana
- Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer
Conditions: Pancreatic Cancer
Location: Baton Rouge, Louisiana
- Fixed-dose Safety and Efficacy Study of Asenapine for the Treatment of Acute Manic or Mixed Episode in Bipolar 1 Disorder (P05691 AM3)
Conditions: Bipolar 1 Disorder
Location: Lake Charles, Louisiana
- A Clinical Study to Evaluate Somo•v and Digital Mammography Together as a Breast Cancer Screening Method, Compared to Digital Mammography Alone, in Wo
Conditions: Breast Cancer
Location: Lafayette, Louisiana
- Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Conditions: Non-Small Cell Lung Cancer - Anemia - Cancer - Lung Cancer
Location: Lafayette, Louisiana
- Safety and Efficacy of Cariprazine for Mania
Conditions: Bipolar Disorder - Mania
Location: Lake Charles, Louisiana
- Tritanium® Primary Acetabular Shell Study
Conditions: Hip Arthropathy
Location: Lake Charles, Louisiana
- A Study of RO4917838 (Bitopertin) in Patients With Persistent, Predominant Negative Symptoms of Schizophrenia (WN25309)
Conditions: Schizophrenia
Location: Lake Charles, Louisiana
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use NSAIDs and/or Colchicine.
Conditions: Acute Gout
Location: Lafayette, Louisiana
- A Study of RO4917838 (Bitopertin) in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (WN25306)
Conditions: Schizophrenia
Location: Lake Charles, Louisiana
- Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
Conditions: Atherosclerosis
Location: Lafayette, Louisiana
- Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
Conditions: Atherosclerosis
Location: Lafayette, Louisiana
- Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
Conditions: Atherosclerosis
Location: Lafayette, Louisiana
- Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
Conditions: Atherosclerosis
Location: Opelousas, Louisiana
- Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
Conditions: Atherosclerosis
Location: Opelousas, Louisiana
- Randomized Study of Laser and Balloon Angioplasty Versus Balloon Angioplasty to Treat Peripheral In-stent Restenosis
Conditions: Peripheral Arterial Disease
Location: Lafayette, Louisiana
- Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Newly Diagnosed, Previously Untreated Multiple Myeloma
Conditions: Multiple Myeloma
Location: Lafayette, Louisiana
- Evaluate the Efficacy and Safety of GSK573719 Delivered Via a Novel Dry Powder Inhaler in Subjects With COPD
Conditions: Chronic Obstructive Pulmonary Disease (COPD)
Location: Sunset, Louisiana
- A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opi
Conditions: Low Back Pain
Location: Lake Charles, Louisiana
- Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled
Conditions: COPD - COPD Exacerbation - Lung Diseases - Respiratory Disorders - Pulmonary Disease - Chronic Obstructive Lung Diseases - Chronic Obstructive Airway Disease
Location: Lafayette, Louisiana
- Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled
Conditions: COPD - COPD Exacerbation - Lung Diseases - Respiratory Disorders - Pulmonary Disease - Chronic Obstructive Lung Diseases - Chronic Obstructive Airway Disease
Location: Opelousas, Louisiana
- Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled
Conditions: COPD - COPD Exacerbation - Lung Diseases - Respiratory Disorders - Pulmonary Disease - Chronic Obstructive Lung Diseases - Chronic Obstructive Airway Disease
Location: Sunset, Louisiana
- Observational Study of the Use of KRYSTEXXA® in Refractory Chronic Gout
Conditions: Chronic Gout
Location: Eunice, Louisiana
- Study of Bortezomib and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma
Conditions: Multiple Myeloma
Location: Lafayette, Louisiana
- Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Conditions: Type 2 Diabetes Mellitus
Location: Eunice, Louisiana
- A Twelve Week, Open Label Extension Study in Patients With Schizophrenia
Conditions: Schizophrenia
Location: Lake Charles, Louisiana
- Efficacy and Safety of Exenatide Once Weekly Suspension in Subjects With Type 2 Diabetes
Conditions: Diabetes Mellitus, Type 2
Location: Lake Charles, Louisiana
- Long Term Safety Study of NVA237 vs QAB149 in COPD Patients
Conditions: Chronic Obstructive Pulmonary Disease (COPD)
Location: Opelousas, Louisiana
- A 12-week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and T
Conditions: Chronic Obstructive Pulmonary Disease (COPD)
Location: Opelousas, Louisiana
- NVA237 BID Versus Placebo Twelve-week Efficacy Study
Conditions: Chronic Obstructive Pulmonary Disease
Location: Sunset, Louisiana
- A Study to Evaluate the Efficacy and Safety of Subcutaneous SCH 900222/MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participa
Conditions: Plaque Psoriasis
Location: Lake Charles, Louisiana
- 2 Week Open-label Pharmacodynamic and Pharmacokinetic Study of Multiple Doses of a Darifenacin Liquid Oral Suspension in Children (2 - 15 Yrs) With Ne
Conditions: Neurogenic Detrusor Overactivity
Location: Lafayette, Louisiana
- This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
Conditions: Heart Failure With Reduced Ejection Fraction
Location: Lafayette, Louisiana
- This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
Conditions: Heart Failure With Reduced Ejection Fraction
Location: Lafayette, Louisiana
- Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907)}(P06107 AM4)
Conditions: Bipolar Disorder, Pediatric
Location: Lake Charles, Louisiana
- A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Conditions: Advanced Prostate Cancer - Prostatic Neoplasms
Location: Crowley, Louisiana
- A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Conditions: Advanced Prostate Cancer - Prostatic Neoplasms
Location: Lafayette, Louisiana
- A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Conditions: Advanced Prostate Cancer - Prostatic Neoplasms
Location: Opelousas, Louisiana
- S1014 Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone Therapy
Conditions: Prostate Cancer
Location: Lafayette, Louisiana
- Smoking Cessation Study In Healthy Adolescent Smokers
Conditions: Smoking Cessation
Location: Lake Charles, Louisiana
- A Study of Avastin (Bevacizumab) in Combination With Standard of Care Treatment in Patients With Lung Cancer
Conditions: Non-Small Cell Lung Cancer
Location: Lafayette, Louisiana
- A Study of Pertuzumab in Addition to Chemotherapy and Herceptin (Trastuzumab) as Adjuvant Therapy in Patients With HER2-Positive Primary Breast Cancer
Conditions: Breast Cancer
Location: Lafayette, Louisiana
- A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children an
Conditions: Major Depressive Disorder
Location: Lake Charles, Louisiana
- A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Conditions: Major Depressive Disorder
Location: Lake Charles, Louisiana
- Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia
Conditions: Acute Schizophrenia
Location: Lake Charles, Louisiana
- Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692AM2)
Conditions: Bipolar I Disorder
Location: Lake Charles, Louisiana
- Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression
Conditions: Depression, Bipolar
Location: Lake Charles, Louisiana
- Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
Conditions: Schizophrenia
Location: Lake Charles, Louisiana
- A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Conditions: Asthma
Location: Sunset, Louisiana
- A Phase 3 Study Comparing the Effects of Subcutaneous Epoetin Hospira and Epoetin Alfa (Amgen) in Patients With Chronic Renal Failure Requiring Hemodi
Conditions: Chronic Renal Failure - Chronic Kidney Disease
Location: Lafayette, Louisiana
- Combining Lesinurad With Allopurinol in Inadequate Responders
Conditions: Gout
Location: Eunice, Louisiana
- Efficacy, Safety, and Tolerability of JNJ-27018966 in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d) (Protocol J
Conditions: Irritable Bowel Syndrome
Location: Lake Charles, Louisiana
- Efficacy, Safety, and Tolerability of JNJ-27018966 in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d) (Protocol J
Conditions: Irritable Bowel Syndrome
Location: Opelousas, Louisiana
- BIOHELIX-I Bare Metal Stent Study
Conditions: Coronary Arteries Lesions
Location: Lafayette, Louisiana
- A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidn
Conditions: Type 2 Diabetes - Chronic Kidney Disease
Location: Lafayette, Louisiana
- A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Anti-TNFa Biologics
Conditions: Inflammation - Rheumatoid Arthritis
Location: Lake Charles, Louisiana
- A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Methotrexate
Conditions: Inflammation - Rheumatoid Arthritis
Location: Lake Charles, Louisiana
- A Phase 3 Long-Term Safety Study of Subcutaneous Epoetin Hospira in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin M
Conditions: Chronic Renal Failure Requiring Hemodialysis
Location: Lafayette, Louisiana
- Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Conditions: Management of Anemia in Chronic Kidney Disease Patients Not on Dialysis.
Location: Lafayette, Louisiana
- Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia
Conditions: Schizophrenia
Location: Lake Charles, Louisiana
- ClearWay Rx Readmission Registry
Conditions: Acute Myocardial Infarction
Location: Lafayette, Louisiana
- A Phase 2 Study to Evaluate ABT-126 for the Treatment of Cognitive Deficits in Schizophrenia
Conditions: Schizophrenia
Location: Lake Charles, Louisiana
- Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia
Conditions: Schizophrenia
Location: Lake Charles, Louisiana
- Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis
Conditions: Psoriasis - Psoriatic Arthritis
Location: Lake Charles, Louisiana
- A Study of Evacetrapib in High-Risk Vascular Disease
Conditions: Cardiovascular Diseases
Location: Lake Charles, Louisiana
- Placebo-controlled Safety and Efficacy Study of Pregabalin in Subjects With Post-traumatic Peripheral Neuropathic Pain
Conditions: Neuropathic Pain
Location: Lake Charles, Louisiana
- Study of Efficacy and Safety of Brodalumab Compared With Placebo and Ustekinumab in Moderate to Severe Plaque Psoriasis Subjects
Conditions: Moderate to Severe Plaque Psoriasis
Location: Lake Charles, Louisiana
- To Evaluate The Effect Of SAR153191 (REGN88) Added To Other RA Drugs In Patients With RA Who Are Not Responding To Or Intolerant Of Anti-TNF Therapy (
Conditions: Rheumatoid Arthritis
Location: Lake Charles, Louisiana
- NOLAN: Naproxen or Loratadine and Neulasta
Conditions: Bone Pain in Stage I - III Breast Cancer
Location: Lafayette, Louisiana
- Study Evaluating TheSafety And Efficacy Of PF-05212377 Or Placebo In Subjects With Alzheimer's Disease With Existing Neuropsychiatric Symptoms On Done
Conditions: Alzheimer's Disease
Location: Lake Charles, Louisiana
- The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Conditions: Irritable Bowel Syndrome Characterized by Constipation
Location: Lake Charles, Louisiana
- Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk
Conditions: Dyslipidemia
Location: Lafayette, Louisiana
- Efficacy and Safety of the Addition of Fluticasone Propionate/Salmeterol (250/50mcg) Twice-daily to 2 Doses of Umeclidinium Bromide Inhalation Powder
Conditions: Pulmonary Disease, Chronic Obstructive
Location: Sunset, Louisiana
- Evaluation of Ixekizumab Using Auto-Injector or Prefilled Syringe in Participants With Moderate to Severe Plaque Psoriasis
Conditions: Plaque Psoriasis
Location: Lake Charles, Louisiana
- AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext
Conditions: Alzheimer's Disease
Location: Lake Charles, Louisiana
- Lurasidone Low-Dose - High-Dose Study Study
Conditions: Schizophrenia
Location: Lake Charles, Louisiana
- Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE)
Conditions: Multiple Myeloma
Location: Lafayette, Louisiana
- A Trial to Assess the Lot Consistency, Safety, Tolerability and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Subjects Aged ≥10 to
Conditions: Meningococcal Vaccine
Location: Eunice, Louisiana
- The Effects of Ranolazine on CPET Parameters in Ischemic Cardiomyopathy Patients (ERIC)
Conditions: Cardiomyopathy
Location: Lafayette, Louisiana
- Efficacy, Safety and Dose-Response Study of Lofexidine in the Treatment of Opioid Withdrawal Followed by Open-Label Lofexidine Treatment
Conditions: Opioid Dependence - Acute Opioid Withdrawal Syndrome
Location: Lake Charles, Louisiana
|